Search for Clinical Trials

This is a randomized, double-blind, placebo-controlled, parallel-group study to verify the clinical benefit of aducanumab (BIIB037) in participants…
  • Alzheimer's Disease
This research study will test the effectiveness of an oral medication, semaglutide, in slowing cognitive decline in people with early Alzheimer’s…
  • Alzheimer's Disease
A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment with BAN2401 in Subjects with…
  • Alzheimer's Disease
A randomized double-blind placebo-controlled phase 2 study to evaluate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of…
  • Psychiatry and Behavior
Introduction: The melanocortin-4 receptor (MC4R) pathway is the principal regulator of mammalian energy balance and body weight. Originating in the…
  • Endocrinology
  • Genetic and Rare Diseases - Treatment
  • Pediatrics
Essential Tremor: A Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled study of botox for the treatment of upper limb essential tremor…
  • Psychiatry and Behavior
Cerevel has begun a study of an investigational drug called CVL-751 (also known as Tavapadon) as a possible treatment for Parkinson's disease.  An…
  • Psychiatry and Behavior
The Study: Along with our research partners at Quadrant Biosciences and Autism Speaks, we are looking for children who present signs of being on the…
  • Autism
  • Genetic and Rare Diseases - Observational and Gene Discovery
  • Growth and Development
  • Pediatrics
A randomized, placebo-controlled, double-blind study to evaluate the effect of Sage-718 on cognitive function in participants with Huntington's…
  • Psychiatry and Behavior
A comparative study of Levodopa and Carbidopa bioavailability following Foslevodopa/Foscarbidopa infusion at different subcutaneous sites in…
  • Psychiatry and Behavior
Back to topback-to-top